Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition

Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition

Tyrosine kinase inhibitors (TKIs) are now the mainstay of treatment in many types of cancer. However, their benefit is frequently short-lived, mandating the search for safe potentiation strategies. Cycles of fasting enhance the activity of chemo-radiotherapy in preclinical cancer models and dietary...

Full description

Bibliographic Details
Main Authors: Caffa, Irene, D'Agostino, Vito, Damonte, Patrizia, Soncini, Debora, Cea, Michele, Monacelli, Fiammetta, Odetti, Patrizio, Ballestrero, Alberto, Provenzani, Alessandro, Longo, Valter D., Nencioni, Alessio
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494907/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494907/

Similar Items